Trial finds aspirin does not speed leg ulcer healing

November 28, 2017, University of Auckland

Suggestions that aspirin may help treat venous leg ulcers have been rebutted by University of Auckland research, leaving the sufferers with compression therapy, a treatment known since the 17th Century.

Venous ulcers are chronic wounds of the lower leg. They are more common in older people. District nurses and general practitioners manage most venous ulcers in the community. They are often painful, disabling and very slow to heal.

About 1 percent of the adult population will develop a venous leg ulcer during any one year. Compression therapy, either in the form of bandage systems or hosiery, is the main treatment. But in of about half the participants remain unhealed after three months of treatment.

Some evidence suggested might increase venous ulcer healing, but a new just published in the British Medical Journal challenges that view.

Funded by the New Zealand Health Research Council and conducted by researchers at the University's National Institute for Health Innovation, Aspirin4VLU trial found 150 mg aspirin a day in addition to compression bandaging did not increase venous ulcer healing.

Seven out of every 10 people with leg ulcers who took aspirin healed within six months compared with eight out of every 10 people in the placebo group.

Associate Professor Andrew Jull who led the trial says while he had hoped aspirin might help with healing, it is still good news. "It means people who have a venous leg ulcer and who have to take aspirin for other reasons still heal at a pretty good rate if they use compression."

The researchers recruited 251 participants through community nursing services in Dunedin, Christchurch, the Waikato, Counties Manukau and Auckland district health boards over two years from 2015.

"We will shortly be getting in touch with the participants to let them and their doctors know which drug they were taking," says Dr Jull. "We remain very grateful to those people who came forward to be part of the study – without them we would not have the evidence to help others."

Aspirin4VLU is the world's largest aspirin trial yet conducted for patients with venous ulcers and the only trial of .

Explore further: Aspirin to improve leg ulcers

More information: Andrew Jull et al. Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU), BMJ (2017). DOI: 10.1136/bmj.j5157

Related Stories

Aspirin to improve leg ulcers

May 25, 2015
Researchers are looking at whether aspirin can improve the healing rates of leg ulcers in older adults.

Exercise may benefit patients with leg ulcers

November 9, 2017
A preliminary British Journal of Dermatology study suggests that ulcers in the legs may heal faster with exercise.

Platelet-rich plasma effective for chronic venous leg ulcers

August 29, 2017
(HealthDay)—For patients with chronic venous leg ulcers, autologous platelet-rich plasma (PRP) is safe and effective, with highly significant improvement in ulcer size compared to conventional treatment, according to a ...

Stockings perform better than bandages to treat leg ulcers

December 5, 2013
A new study has found that leg ulcers take the same time to heal when people wear compression stockings rather than traditional bandages.

Improved leg ulcer healing with hair follicle punch graft

October 25, 2016
(HealthDay)—For patients with venous leg ulcers, ulcer healing is significantly increased using hair follicle punch scalp grafts, according to a study published in the November issue of the Journal of the American Academy ...

Recommended for you

Novel molecular target to prevent scarring of the lung blood vessels identified

June 13, 2018
Pulmonary arterial hypertension, a severe form of cardiopulmonary disease in which the arteries that transport blood from the heart to the lungs become thickened, constricted, and scarred, is a disease for which there is ...

Fast-acting cholera vaccine could curb outbreaks

June 13, 2018
A tricked-out cholera vaccine starts protecting against the deadly disease within a day, experiments in rabbits suggest. The rapid protection offered by this designer vaccine may one day limit the spread of cholera outbreaks, ...

Lineage of TB traced and compared to early human migration

June 13, 2018
A team of researchers from the University of Wisconsin, the University of Iowa and the Norwegian Institute of Public Health has carried out genetic studies of tuberculosis to learn more about its lineage and to compare it ...

Finally, hope for a syphilis vaccine

June 12, 2018
Despite efforts to eradicate it, syphilis is on the rise. Until now, most health agencies focused on treating infected people and their sex partners but new discoveries may make a vaccine possible, UConn Health researchers ...

How to slow down Ebola—Virologists use 'genetic trees' to evaluate intervention strategies

June 12, 2018
The phylogenetic tree of the 2013-2016 Ebola epidemic doesn't just reveal how the Ebola virus was able to evolve—it also reveals which events and preventive measures accelerated or slowed down its spread. These findings ...

Small children and pregnant women may be underdosed in current malaria regimen

June 12, 2018
Current recommended dosing regimens for the most widely used treatment for uncomplicated Plasmodium falciparum malaria may be sub-optimal for the most vulnerable populations of patients, according to a study published this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.